Latest Insider Transactions at Cen Biotech Inc (CENBF)
This section provides a real-time view of insider transactions for Cen Biotech Inc (CENBF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CEN BIOTECH INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CEN BIOTECH INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 06
2021
|
Rick Leigh Purdy SVP of Deals and Acquisitions |
BUY
Grant, award, or other acquisition
|
Direct |
2,500,000
+47.09%
|
-
|
Jun 25
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+26.48%
|
-
|
Jun 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.11%
|
-
|
May 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
Apr 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
Apr 10
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
30,000
+1.66%
|
$30,000
$1.6 P/Share
|
Apr 02
2021
|
Donald Strilchuck Director |
BUY
Grant, award, or other acquisition
|
Direct |
341,250
+20.04%
|
-
|
Apr 02
2021
|
De Lavenu Harold Andre Aubrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041,250
+39.07%
|
-
|
Apr 02
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+14.47%
|
-
|
Apr 02
2021
|
Ameen Ferris Vice President* |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+49.51%
|
-
|
Apr 02
2021
|
Bahige B. Chaaban Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,106,122
+22.02%
|
-
|
Apr 02
2021
|
Brian Payne Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,435,000
+39.38%
|
-
|
Apr 02
2021
|
Richard Boswell Senior Executive VP |
BUY
Grant, award, or other acquisition
|
Direct |
2,185,679
+26.7%
|
-
|
Apr 02
2021
|
Usamakh Saadikh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+49.51%
|
-
|
Mar 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
Feb 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
Jan 27
2021
|
Richard Boswell Senior Executive VP |
SELL
Open market or private sale
|
Direct |
6,250
-0.1%
|
$0
$0.8 P/Share
|
Jan 26
2021
|
Richard Boswell Senior Executive VP |
SELL
Open market or private sale
|
Direct |
37,500
-0.62%
|
$0
$0.4 P/Share
|
Jan 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|